V

Vericel Corp
D

VCEL

38.935
USD
1.03
(2.70%)
مغلق
حجم التداول
24,683
الربح لكل سهم
0
العائد الربحي
-
P/E
195
حجم السوق
1,952,039,865
أصول ذات صلة
C
CKPT
0.00000
(0.00%)
4.12000 USD
M
MESO
0.130
(1.09%)
12.070 USD
V
VSTM
0.02000
(0.27%)
7.43000 USD
المزيد
الأخبار المقالات

العنوان: Vericel Corp

القطاع: Healthcare
الصناعة: Biotechnology
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.